Postantibiotic and Sub-Mic Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity Against Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02616-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search